AKT1 and breast cancer: The majority of breast cancers display an alteration in the PI3K/AKT pathway, most frequently through somatic hotspot mutations in exons 9 and 20 of PIK3CA, leading to cell growth, proliferation, angiogenesis, and cell survival.